GEHC Key Statistics, Chart & Performance
The current stock price of GEHC is 80.65 USD. In the past month the price decreased by -8.52%. In the past year, price decreased by -7.98%.
GEHC Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to GEHC. When comparing the yearly performance of all stocks, GEHC turns out to be only a medium performer in the overall market: it outperformed 43.09% of all stocks.
GEHC Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to GEHC. GEHC scores excellent on profitability, but there are concerns on its financial health.
GEHC Financial Highlights
Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.58. The EPS increased by 2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.95% | ||
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| Debt/Equity | 0.83 |
GEHC Forecast & Estimates
28 analysts have analysed GEHC and the average price target is 94.06 USD. This implies a price increase of 16.63% is expected in the next year compared to the current price of 80.65.
For the next year, analysts expect an EPS growth of 9.67% and a revenue growth 4.34% for GEHC
GEHC Ownership
GEHC Latest News, Press Relases and Analysis
GEHC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.3 | 192.719B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.76 | 173.049B | ||
| SYK | STRYKER CORP | 23.7 | 137.017B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 113.066B | ||
| BDX | BECTON DICKINSON AND CO | 14.13 | 59.944B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.472B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.47 | 45.675B | ||
| RMD | RESMED INC | 22.12 | 39.65B | ||
| DXCM | DEXCOM INC | 27.71 | 27.29B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GEHC
Company Profile
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Company Info
GE HEALTHCARE TECHNOLOGY
500 West Monroe Street
Chicago ILLINOIS US
Employees: 53000
Phone: 18337351139
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What does GEHC do?
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
What is the current price of GEHC stock?
The current stock price of GEHC is 80.65 USD. The price decreased by -2.02% in the last trading session.
Does GE HEALTHCARE TECHNOLOGY pay dividends?
GE HEALTHCARE TECHNOLOGY (GEHC) has a dividend yield of 0.17%. The yearly dividend amount is currently 0.12.
What is the ChartMill technical and fundamental rating of GEHC stock?
GEHC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is GE HEALTHCARE TECHNOLOGY (GEHC) stock traded?
GEHC stock is listed on the Nasdaq exchange.
What is the market capitalization of GEHC stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a market capitalization of 36.74B USD. This makes GEHC a Large Cap stock.
Can you provide the upcoming earnings date for GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) will report earnings on 2026-04-27.